公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2024 | Weight and metabolic changes among virally-suppressed people living with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide | Hsu, Jen-Yu; HSIN-YUN SUN ; Chen, Ling-Ya; SUI-YUAN CHANG ; YU-CHUNG CHUANG ; YU-SHAN HUANG ; Su, Yi-Ching; Liu, Wen-Chun; CHIEN-CHING HUNG | Journal of global antimicrobial resistance | |||
2020 | Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Kuo P.-H.; HSIN-YUN SUN ; YU-CHUNG CHUANG ; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG | International Journal of Infectious Diseases | 36 | 40 |